These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 26402907)
1. A KSHV microRNA Directly Targets G Protein-Coupled Receptor Kinase 2 to Promote the Migration and Invasion of Endothelial Cells by Inducing CXCR2 and Activating AKT Signaling. Hu M; Wang C; Li W; Lu W; Bai Z; Qin D; Yan Q; Zhu J; Krueger BJ; Renne R; Gao SJ; Lu C PLoS Pathog; 2015 Sep; 11(9):e1005171. PubMed ID: 26402907 [TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis. Ramalingam D; Happel C; Ziegelbauer JM J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082 [TBL] [Abstract][Full Text] [Related]
3. Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection. Lee MS; Jones T; Song DY; Jang JH; Jung JU; Gao SJ PLoS Pathog; 2014 Sep; 10(9):e1004412. PubMed ID: 25254972 [TBL] [Abstract][Full Text] [Related]
4. KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprin-induced signal transduction. Dai L; Bratoeva M; Toole BP; Qin Z; Parsons C Int J Cancer; 2012 Aug; 131(4):834-43. PubMed ID: 21918972 [TBL] [Abstract][Full Text] [Related]
5. The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility. Wu YH; Hu TF; Chen YC; Tsai YN; Tsai YH; Cheng CC; Wang HW Blood; 2011 Sep; 118(10):2896-905. PubMed ID: 21715310 [TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Wang L; Damania B Cancer Res; 2008 Jun; 68(12):4640-8. PubMed ID: 18559509 [TBL] [Abstract][Full Text] [Related]
7. Tonic inhibition by G protein-coupled receptor kinase 2 of Akt/endothelial nitric-oxide synthase signaling in human vascular endothelial cells under conditions of hyperglycemia with high insulin levels. Taguchi K; Sakata K; Ohashi W; Imaizumi T; Imura J; Hattori Y J Pharmacol Exp Ther; 2014 May; 349(2):199-208. PubMed ID: 24570070 [TBL] [Abstract][Full Text] [Related]
8. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Montaner S; Sodhi A; Pece S; Mesri EA; Gutkind JS Cancer Res; 2001 Mar; 61(6):2641-8. PubMed ID: 11289142 [TBL] [Abstract][Full Text] [Related]
9. Kaposi Sarcoma Herpesvirus Induces HO-1 during De Novo Infection of Endothelial Cells via Viral miRNA-Dependent and -Independent Mechanisms. Botto S; Totonchy JE; Gustin JK; Moses AV mBio; 2015 Jun; 6(3):e00668. PubMed ID: 26045540 [TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Bais C; Van Geelen A; Eroles P; Mutlu A; Chiozzini C; Dias S; Silverstein RL; Rafii S; Mesri EA Cancer Cell; 2003 Feb; 3(2):131-43. PubMed ID: 12620408 [TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus encodes a mimic of cellular miR-23. Manzano M; Shamulailatpam P; Raja AN; Gottwein E J Virol; 2013 Nov; 87(21):11821-30. PubMed ID: 23986579 [TBL] [Abstract][Full Text] [Related]
13. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma. Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770 [TBL] [Abstract][Full Text] [Related]
14. Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration. Giffin L; West JA; Damania B mBio; 2015 Dec; 6(6):e01499-15. PubMed ID: 26646010 [TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCγ1 and activating NFAT1-dependent RCAN1 expression. Bala K; Bosco R; Gramolelli S; Haas DA; Kati S; Pietrek M; Hävemeier A; Yakushko Y; Singh VV; Dittrich-Breiholz O; Kracht M; Schulz TF PLoS Pathog; 2012 Sep; 8(9):e1002927. PubMed ID: 23028325 [TBL] [Abstract][Full Text] [Related]
16. KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway. Burger M; Hartmann T; Burger JA; Schraufstatter I Oncogene; 2005 Mar; 24(12):2067-75. PubMed ID: 15688008 [TBL] [Abstract][Full Text] [Related]
17. A systems biology approach identified different regulatory networks targeted by KSHV miR-K12-11 in B cells and endothelial cells. Yang Y; Boss IW; McIntyre LM; Renne R BMC Genomics; 2014 Aug; 15(1):668. PubMed ID: 25106478 [TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection. Zhang X; Wang JF; Chandran B; Persaud K; Pytowski B; Fingeroth J; Groopman JE J Biol Chem; 2005 Jul; 280(28):26216-24. PubMed ID: 15878864 [TBL] [Abstract][Full Text] [Related]
19. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway. Zhu X; Guo Y; Yao S; Yan Q; Xue M; Hao T; Zhou F; Zhu J; Qin D; Lu C Oncogene; 2014 Apr; 33(15):1986-96. PubMed ID: 23604117 [TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection. Qin Z; Dai L; Defee M; Findlay VJ; Watson DK; Toole BP; Cameron J; Peruzzi F; Kirkwood K; Parsons C J Virol; 2013 Jan; 87(1):621-35. PubMed ID: 23097457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]